Piramal to invest $10m to add ADC capacity at Coldstream lab

By Staff Reporter

- Last updated on GMT

Piramal to invest $10m to add ADC capacity at Coldstream lab
Piramal has announced its intention to invest $10m (€8.9m) in Coldstream Laboratories, the US sterile injectable CDMO it bought last year.

The investment will be focused at Coldstream’s facility near Lexington, Kentucky and will create 40 new jobs according to the Indian contractor.

The move is being supported by tax incentives of up to $800,000 from the Kentucky Economic Development Finance Authority (KEDFA).

William Wedlake, president of Piramal’s formulations business, said the investment fits with the growth of the firms antibody drug conjugates (ADC) business.

In addition to developing new clients, the Kentucky facility also allows our current ADC clients to forward integrate seamlessly and address their fill-finish needs​” he said.

The expansion will also add specialist containment and chemical handling capabilities according to Wedlake.

As oncology becomes key in our collaborators portfolio, our ability to handle high potency APIs, develop and deliver high quality, robust, cost effective drug product solutions becomes a key differentiator​.”

Piramal bought Coldstream last January for $30.65m.

Founded in 2007 and by University of Kentucky Research Foundation, Coldstream employs 91 people and focuses on the manufacturing of sterile liquid and lyophilized parenterals and injectables.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars